Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo

Blood

Volumn 97, Issue 6, 2001, Pages 1703-1711

  Lluís, Frederic ^b   Roma, Josep ^b   Suelves, Mònica ^b   Parra, Maribel ^b   Aniorte, Gloria ^b   Gallardo, Eduard ^b   Illa, Isabel ^b   Rodríguez, Luciano ^b   Hughes, Simon M ^b   Carmeliet, Peter ^b   Roig, Manuel ^b   Muñoz Cánoves, Pura ^a  

^a Institut de Recerca Oncologica   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBRIN DEPOSITION; MONOCYTE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MYOSITIS; MYOTUBE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKELETAL MUSCLE;

EID: 0035869496     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.6.1703     Document Type: Article

References (35)

1. The plasminogen activator system: Biology and regulation
2. Macrophages and dendritic cells in normal and regenerating murine skeletal muscle
3. Migration of myoblasts across basal lamina during skeletal muscle development
4. Rat myoblast fusion requires metalloendoprotease activity
5. Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells
6. A metalloprotease-disintegrin participating in myoblast fusion
7. Gene trapping in differentiating cells lines: Regulation of the lysosomal protease cathepsin B in skeletal myoblast growth and fusion
8. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: A study in experimentally injured and mdx muscles
9. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes
10. Plasminogen activator in chick embryo muscle cells: Induction of enzyme by RSV, PMA and retinoic acid
11. Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro
12. Slow and fast rat skeletal muscles differ in their plasminogen activator activities
13. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro
14. Physiological consequences of loss of plasminogen activator gene function in mice
15. Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice
16. Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice: An autoradiographic study
17. Experimental glycerol myopathy: A histological study
18. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chlorophorm extraction
19. Differential regulation of urokinase-type plasminogen activator expression by basic fibroblast growth factor and serum in myogenesis: Requirement of a common mitogen-activated protein kinase pathway
20. MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse
21. Molecular and cellular biology of muscle regeneration
22. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
23. Monoclonal antibodies specific for endothelial cells of mouse blood vessels: Their application in the identification of adult and embryonic endothelium
24. Regulation and control of the fibrinolytic system
25. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (Agkistrodon rhodostoma) or prothrombin and fibrinogen metabolism and fibrinopeptide A release in man
26. Impaired wound healing in mice with a disrupted plasminogen gene
27. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
28. Analysis of inflammatory cells and complement C3 in bupicavine-induced myonecrosis
29. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: A murine transgenic model
30. Endogenously produced urokinase amplifies tumor necrosis factor-alpha secretion by THP-1 mononuclear phagocytes
31. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis
32. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
33. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β
34. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells
35. MyoD is required for myogenic stem cell function in adult skeletal muscle